Giovanni A. Tommaselli

ORCID: 0000-0001-8501-912X · 8 papers in corpus · active 2008-2015

Study types

  • article 8

Condition tags

  • endometriosis 1
  • endometrioma 1
article 2015
·doi:10.1007/s00404-015-3750-x
article 2014
·doi:10.3109/09513590.2014.975688

This is an observational study on 102 women aged 25-45 years to evaluate if the E2V/DNG pill has any impact on quality of life (QoL) and sexual function (FSF). Thirty-nine women were younger than 35 years (group A), and 63 women were 35 yea…

article 2014
·doi:10.1007/s10397-014-0854-4
article 2013
·doi:10.3109/09513590.2013.831834

This study shows the effect of a 1 year treatment with an estradiol valerate/dienogest pill in 36 women suffering from polycystic ovaries and mild or moderate acne. At beginning of the study, 24 patients (66.7%) had grade 1-2 (mild) acne an…

article 2013
·doi:10.3109/13625187.2013.811483

OBJECTIVES: To evaluate the effects of a combined oral contraceptive (COC) containing dienogest/oestradiol valerate (DNG/E2V) on bone mineral density (BMD) and on serum and urinary bone turnover markers in young, healthy, fertile women. MET…

article 2012
·doi:10.1016/s0020-7292(12)61342-3
article 2012
·doi:10.3109/09513590.2012.683078

To investigate the impact of a 3 months preoperative administration of an oral contraceptive, containing dienogest (DNG) and estradiol valerate (E₂V) on the outcome of office operative hysteroscopy (OOH). One-hundred and forty-two patients …

article 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.03.079